Last week, three of the UK’s most senior health officials visited Guy’s Hospital to tour our NIHR Biomedical Research Centre (BRC) and Clinical Research Facility (CRF).

Lord Prior of Brampton, Parliamentary Under Secretary of State for NHS Productivity; Professor Dame Sally Davies, the UK’s Chief Medical Officer; and Professor Chris Whitty, Chief Scientific Adviser for the Department of Health, were visiting the BRC to hear from researchers and patients about our advanced therapy clinical trials and the crucial role our BRC and CRF infrastructure and staff play in delivering the programme of experimental medicine.

In addition to meeting staff the delegation, which included the Chairman of Guy’s and St Thomas’ NHS Foundation Trust Sir Hugh Taylor, also spent time with Michael McAdam a volunteer on our pioneering ‘ONE Study’ trial and regular visitor to the CRF.

The tour was led by Professor Graham Lord, Director of the NIHR Biomedical Research Centre (BRC) at Guy’s and St Thomas’ and King’s College London, who said: “We were delighted to welcome such distinguished guests to our facility. I was particularly pleased that they had the time to meet one of our committed trial participants.

“The world-class research facilities available at Guy’s and St Thomas’ play a vital role in helping us in our mission to translate excellent research into state-of-the-art clinical practice. This visit provided an excellent opportunity to showcase the difference we are making.”

About The ONE Study
The ONE Study was a first-in-man clinical trial which utilised the CRF’s facilities and staff to investigate the use of naturally occurring regulatory T-cells as adoptive therapies to counter kidney rejection following transplant.

The ONE Study has now completed, but you can find our more about our other trials at: http://www.guysandstthomasbrc.nihr.ac.uk/Homepage.aspx or by visiting the UK Clinical Trials Gateway website: https://www.ukctg.nihr.ac.uk/